Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: A before and after clinical trial

Nutrition Journal

Volumn 4, Issue , 2005, Pages

  Roudsari, Arezoo Haghighian ^a   Tahbaz, Farideh ^a   Hossein Nezhad, Arash ^b   Arjmandi, Bahram ^c   Larijani, Bagher ^b   Kimiagar, Seyed Masoud ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; DEOXYPYRIDINOLINE; OSTEOCALCIN; PHYTOESTROGEN; SOYBEAN PROTEIN;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; BONE TURNOVER; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG RESEARCH; DRUG SCREENING; FEMALE; FOOD INTAKE; FOOD PROCESSING; HUMAN; IRAN; NUTRIENT; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PHYSICAL ACTIVITY; POSTMENOPAUSE; PROTEIN INTAKE; RECALL; URINALYSIS;

ALKALINE PHOSPHATASE; AMINO ACIDS; BONE REMODELING; COLLAGEN; COLLAGEN TYPE I; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; IRAN; MENOPAUSE; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDES; PHYTOESTROGENS; SOYBEAN PROTEINS; SOYBEANS;

GLYCINE MAX;

EID: 28644445942     PISSN: 14752891     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-4-30     Document Type: Article

References (37)

1. Barrett CE: Epidemiology and the menopause:A global overview. Int J Fertil 1993, 38:6-14.
2. Dempster DW, Lindsay R: Pathogenesis of osteoporosis. Lancet 1996, 341:797-801.
3. Position statement of the north american menopause society: Management of postmenopausal osteoporosis. Menopause 2002, 9(2):84-101.
4. Scharbo DM: Hormone replacement therapy. Nurse Pract 1996, 21:1-13.
5. Groeneveld FP, Bareman FP, Barensen r, et al.: Determinants of first prescription of hormone replacement therapy. A follow up study among 1689 women aged 45-60 years. Maturitas 1994, 20:81-89.
6. Lignieres DB: Hormone replacement therapy: clinical benefits and side-effects. Maturitas 1996:31-36.
7. Glazier MG, Bowman MA: A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch Intern Med 2001, 161:1161-1172.
8. Ross PD, Norimatsu H, Davis JW, Yano K, Wasnich RD, et al.: A comparison of hip frcture incidence amonge native Japanese, Japanese Americans, and American Caucasians. Am J Epidemiol 1991, 133:801-809.
9. Adlercreutz H, Mazur W: Phytoestrogens and Western diseases. Ann Med 1997, 29:95-120.
10. Simoon F: Food in china: a cultural and historical inquiry. Boca Raton, FL: CRC press Inc; 1991.
11. Kurzer MS, Xu X: Dietary phytoestrogens. Ann Rev Nutr 1997, 17:353-381.
12. Coward L, Barnes NC, Setchell EDR, Barnes S: Genistein, daidzein and their β-glucoside conjugates: antitumor isoflavones in soybean foods from American diets and Asian diets. J Agri Food Chem 1993, 41:1961-1967.
13. Messina MJ: Legumes and soybeans: Overview of their nutritional profiles and health effects. Am J Clin Nutr 1999:439-450.
14. Wangen KE, Duncan AM, Merz-Demlow BE, et al.: Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab 2000, 85:3043-3048.
15. Kuiper GG, Carisson B, Grandien K, et al.: Comparison of the ligand binding specifity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138:863-870.
16. National Nutrition Institute: National food consumption survey report. Tehran, Iran. 1995.
17. Watts NB: Clinical utility of biochemical markers of bone remodeling. Clin Chem 1999, 45(8 Pt 2):1359-1368.
18. Arjmandi BH, Alekel L, Hollis BW, Amin D, et al.: Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nut 1996, 126:161-167.
19. Arjmandi BH, Getlinger MJ, Goyal NV, Alekel l, Hasler CM, et al.: Role of soy protein with normal or reduced isoflaonecontent in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr 1998:1358-1363.
20. Arjmandi BH, Birnbaum R, Goyal NV, Getlinger MJ, et al.: Bone sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content. Am J Clin Nutr 1998:1364-1368.
21. Chang YC, Nair MG: Metabolism of daidzein and genistein by intestinal bacteria. J Nutr Proc 1995, 58:1892-1896.
22. Xu X, Harris KS, Wang HJ, Murphy PA, Hendrich S: Bioavailability of soybean isoflavones depends upon gut microflora in women. J Nutr 1995, 125:2307-2315.
23. Sathyamoorthy N, Wang TTY: Differential effects of dietary phyto-oestrogens daidzein and equol on human breast cancer MCF-7 cells. Eur J Cancer 1997, 33:2384-2389.
24. Setchell KDR, Adlercreutz H: Mammalian lignans and phytoestrogens: recent studies on their formation, metabolism, and biological role in health and disease. In Role of the gut flora in toxicity and cancer Edited by: Rowland IR. Academic Press. London, United Kingdom; 1988:315-345.
25. Register TC, Jayo MJ, Anthony MS: Soy phytoestrogens do not prevent bone loss in postmenopausal monkeys. J Clin Endocrinol Metab 2003, 88:4362-4370.
26. Clarkson TB, Anthony MS, Morgan TM: Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab 2001, 86(1):41-47.
27. Setchell KD, Brown NM, Lydeking-Olsen E: The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 2002, 132(12):3577-3584.
28. Arjmandi Bh, Khalil DA, Smith BJ, et al.: soy protein has a greater effect on bone in postmenopausalwomen not on hormon replacement therapy as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab 2003, 88:1048-1054.
29. Yamori Y, Moriguchi EH, Teramoto T, Miura A, et al.: Soybean isoflavones reduce postmenopausal bone resorption in female Japanese immigrants in Brazil:A ten week study. J Am Coll Nutr 2002, 21(6):560-563.
30. Picherit C, Pelissero CB, Chanteranne B, Lebecque P, et al.: Soybean isofavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J Nutr 2001, 131:723-728.
31. Uesugi T, Fukui Y, Yamori Y: Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four week study. J Am Coll Nutr 2002, 21:97-102.
32. Fanti P, Monier-Faugere MC, Geng Z, et al.: The phytoestrogen genistein reduces bone loss in short term ovariectomized rats. Osteoporosis Int 1998, 8:274-281.
33. Agnusdei D, Crepaldi G, Isaia G, et al.: A double blind, placibo controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss. Calcif Tissue Int 1997, 61:142-147.
34. Gennari C, Agnusdei D, Crepaldi G, et al.: Effect of ipriflavone-a synthetic derivative of natural isoflavones-on bonemass loss in the early years after menopause. Menopause 1998, 5:9-15.
35. Potter SM, Baum JA, Teng H, Stillman RJ, et al.: Soy protein and isoflavone: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998, 68(suppl 6):1375-1379.
36. Alekel DL, Germain AS, Peterson CT, Hanson KB, et al.: Isoflavonerich soy protein isolate attenuates bone loss in the lumbar spine of perimenopusal women. Am J Clin Nutr 2000, 72:844-852.
37. Barnes S: Phytoestrogens and osteoporosis - What is a safe dose? Br J Nutr 2003, 39:101-108.